Clinical Trial Update: Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating docetaxel, carboplatin, and trastuzumab with or without lapatinib in women with surgically resectable Stage I–III breast cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Lapatinib (Lapatinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Translational Oncology Research International | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED